Peter V. Pallai

2.1k total citations
30 papers, 1.8k citations indexed

About

Peter V. Pallai is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter V. Pallai has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter V. Pallai's work include Chemical Synthesis and Analysis (9 papers), Computational Drug Discovery Methods (4 papers) and Viral Infections and Immunology Research (4 papers). Peter V. Pallai is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Computational Drug Discovery Methods (4 papers) and Viral Infections and Immunology Research (4 papers). Peter V. Pallai collaborates with scholars based in United States, Austria and Brazil. Peter V. Pallai's co-authors include Malcolm J. McGregor, Olli Carpén, Donald E. Staunton, Timothy A. Springer, Murray Goodman, Eckard Wimmer, Richard H. Ingraham, M. T. SKOOG, Martin J.H. Nicklin and K S Harris and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Peter V. Pallai

29 papers receiving 1.7k citations

Peers

Countries citing papers authored by Peter V. Pallai

Since Specialization

Citations

This map shows the geographic impact of Peter V. Pallai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter V. Pallai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter V. Pallai more than expected).

Fields of papers citing papers by Peter V. Pallai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter V. Pallai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter V. Pallai. The network helps show where Peter V. Pallai may publish in the future.

Co-authorship network of co-authors of Peter V. Pallai

This figure shows the co-authorship network connecting the top 25 collaborators of Peter V. Pallai. A scholar is included among the top collaborators of Peter V. Pallai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter V. Pallai. Peter V. Pallai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring protein hotspots by optimized fragment pharmacophores 2021 ·Nature Communications ·Dávid Bajusz, Warren S. Wade, Grzegorz Satała, Andrzej J. Bojarski, Janez Ilaš, (unknown), Florian Grebien, Henrietta Papp, Ferenc Jakab, A. Douangamath, D. Fearon, F. von Delft, M. Schuller, Ivan Ahel, Amanda Wakefield, Sándor Vajda, (unknown), Peter V. Pallai, György M. Keserű	31
2	Abstract 2180: Drug-like inhibitors of SGK1: Discovery and optimization of low molecular weight fragment leads 2016 ·Cancer Research ·James Zapf, Todd Meyer, Warren S. Wade, Laura Lingardo, Ayse Batova, Gordon Alton, Peter V. Pallai	2
3	The Synthesis and Selective IL-2 Inhibitory Activity of Bis Piperazine–Phenol Mannich Adducts 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Paul Fleming, (unknown), (unknown), Peter V. Pallai	5
4	ChemInform Abstract: Clustering of Large Databases of Compounds: Using the MDL “Keys” as Structural Descriptors 1997 ·ChemInform ·Malcolm J. McGregor, Peter V. Pallai	1
5	Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities 1996 ·Antimicrobial Agents and Chemotherapy ·Stefano Rusconi, Mona Moonis, Debra P. Merrill, Peter V. Pallai, (unknown), Sunit K. Singh, (unknown), Marcia S. Osburne, Albert T. Profy, James C. Jenson, M. S. Hirsch	131
6	Lipophilic bis-arylsulfonates as inhibitors of the CD4-gp120 interaction 1996 ·Bioorganic & Medicinal Chemistry Letters ·Raymond J. Patch, John Roberts, Huai Gao, Zhongbing 中兵 Shi 石, Ariamala Gopalsamy, (unknown), Kevin M. Daniels, Paul Kowalczyk, (unknown), (unknown), Peter V. Pallai	7
7	Asymmetric synthesis of two-residue modules designed for mimicry of beta strands 1995 ·Tetrahedron Letters ·J. C. Roberts, Peter V. Pallai, Julius Rebek	5
8	Conformation of CD4‐derived cyclic hexapeptides by nmr and molecular dynamics 1994 ·Biopolymers ·(unknown), Malcolm J. McGregor, Fred E. Cohen, Peter V. Pallai	5
9	Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding. 1993 ·Proceedings of the National Academy of Sciences ·Ulrich Moebius, Peter V. Pallai, Stephen C. Harrison, Ellis L. Reinherz	66
10	Proteolytic processing of the cardioviral P2 region: Primary 2A/2B cleavage in clone-derived precursors 1992 ·Virology ·Ann C. Palmenberg, Griffith D. Parks, David J. Hall, Richard H. Ingraham, Thomas Seng, Peter V. Pallai	61
11	The characterization of crude products from solid-phase peptide synthesis by mu-HPLC/fast atom bombardment mass spectrometry. 1992 ·PubMed ·(unknown), Walter Davidson, G.E. Hansen, David H. Freeman, Peter V. Pallai	1
12	Association of intercellular adhesion molecule-1 (ICAM-1) with actin-containing cytoskeleton and alpha-actinin. 1992 ·The Journal of Cell Biology ·Olli Carpén, Peter V. Pallai, Donald E. Staunton, Timothy A. Springer	266
13	Cleavage of synthetic peptides by purified poliovirus 3C proteinase 1989 ·Journal of Biological Chemistry ·Peter V. Pallai, (unknown), M. T. SKOOG, (unknown), (unknown), K.A. Cohen, Guido Hansen, (unknown), K S Harris, Martin J.H. Nicklin, (unknown)	86
14	Polypeptide 2A of human rhinovirus type 2: Identification as a protease and characterization by mutational analysis 1989 ·Virology ·Wolfgang Sommergruber, (unknown), Dieter Blaas, (unknown), (unknown), Ingrid Maurer-Fogy, Peter V. Pallai, Vincent J. Merluzzi, (unknown), Tim Skern, Ernst Kuechler	65
15	Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides. 1989 ·Proceedings of the National Academy of Sciences ·Hans‐Georg Kräusslich, Richard H. Ingraham, M. T. SKOOG, Eckard Wimmer, Peter V. Pallai, (unknown)	142
16	Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro 1988 ·Journal of Virology ·Martin J.H. Nicklin, K S Harris, Peter V. Pallai, Eckard Wimmer	89
17	Structural homology of corticotropin-releasing factor, sauvagine, and urotensin I: circular dichroism and prediction studies. 1983 ·Proceedings of the National Academy of Sciences ·Peter V. Pallai, (unknown), Murray Goodman, Wylie Vale, Jean Rivier	53
18	Approaches to the synthesis of retro‐inverso peptides 1983 ·International journal of peptide & protein research ·Peter V. Pallai, Sumner Richman, R. Scott Struthers, Murray Goodman	25
19	Preparation of optically pure monoacyl 2-alkyl gem-diamines from peptide amides 1982 ·Journal of the Chemical Society Chemical Communications ·Peter V. Pallai, Murray Goodman	35
20	STANDARDIZATION OF SPECIFIC RADIOIMMUNOASSAYS FOR PLASMA PROGESTERONE, ESTRADIOL, ESTRONE AND ANDROSTENEDIONE 1974 ·European Journal of Endocrinology ·E Friedrich, (unknown), (unknown), (unknown), Botond Penke, Peter V. Pallai, E. Keller, A. E. Schindler	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact